Racura Oncology Ltd (ASX:RAC)
Australia flag Australia · Delayed Price · Currency is AUD
2.150
-0.100 (-4.44%)
Aug 28, 2026, 4:10 PM AEST

Racura Oncology Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
441434204311200311
Market Cap Growth
103.13%112.66%-34.32%55.59%-35.78%-41.00%
Enterprise Value
407413185297173274
Last Close Price
2.252.221.181.821.231.95

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
156.91154.4138.8577.6363.73439.48
PB Ratio
12.1011.9112.7516.977.848.62
P/TBV Ratio
12.9012.7015.1420.058.929.50

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
144.71146.9735.2874.2155.32387.06

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Debt / Equity Ratio
-0.94-0.94-0.85-0.94-0.84-0.93
Net Debt / EBITDA Ratio
3.393.392.621.212.113.07
Net Debt / FCF Ratio
4.164.162.991.802.025.36
Asset Turnover
0.100.100.280.170.100.03
Quick Ratio
21.2821.289.429.2620.1623.71
Current Ratio
21.4321.4310.299.3220.4424.10
Return on Equity (ROE)
-42.27%-42.27%-27.89%-63.10%-32.22%-44.96%
Return on Assets (ROA)
-23.39%-23.39%-18.24%-38.63%-20.41%-27.05%
Return on Capital Employed (ROCE)
-28.50%-28.50%-34.30%-78.90%-41.10%-31.00%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-2.51%-2.55%-2.34%-4.45%-4.97%-3.60%
FCF Yield
-1.87%-1.90%-2.24%-3.07%-5.33%-2.01%
Buyback Yield / Dilution
-3.90%-3.90%-4.81%-2.35%-4.83%-17.06%